Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection
Shuo Sun(Chinese Academy of Sciences), Yun Chen(Southeast University), Hong Xiao(Army Medical University), Qianqian Zhao(Nanjing Medical University), Kun Yang(Hainan Medical College Hospital), Chupeng Hu(Jiangsu Cancer Hospital), Jian Liu(University of Missouri Health System), Jing Ji(Jiangsu Province Hospital), Haisi Wu(Nanjing Medical University), Hongyi Liu(Southern University of Science and Technology), Yu Jin(Nanjing Medical University), Wei Gu(Jiangsu Province Hospital), Shiyu Qian(Nanjing Medical University), Huae Xu(China Pharmaceutical University), Ye Gao(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 52
Related Papers
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice
|Nature Medicine|2009|775
Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer
|Nucleic Acids Research|2020|228
Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
|Hepatology|2022|181
Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury
|Nature Communications|2021|140
Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1
|Cell Death and Disease|2022|123